Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02760433
Brief Title: Evaluation of the Effectiveness and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking an Existing Medication Called a Tumour Necrosis Factor Alpha Inhibitor But Have Active Disease (CREDO 3)

First Submitted : April 29, 2016
First Submitted that Met QC Criteria : May 2, 2016
First Posted : May 3, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : November 30, 2018
Last Update Posted : December 3, 2018